GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Globus Medical Inc (NYSE:GMED) » Definitions » EPS without NRI

Globus Medical (Globus Medical) EPS without NRI : $2.26 (TTM As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Globus Medical EPS without NRI?

Globus Medical's earnings per share without non-recurring items for the three months ended in Dec. 2023 was $0.60. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was $2.26.

During the past 12 months, Globus Medical's average earnings per share (NRI) Growth Rate was -25.90% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 10.80% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 0.10% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Globus Medical's EPS without NRI or its related term are showing as below:

GMED' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -7.3   Med: 10.3   Max: 14.1
Current: 10.8

During the past 13 years, Globus Medical's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 14.10% per year. The lowest was -7.30% per year. And the median was 10.30% per year.

GMED's 3-Year EPS without NRI Growth Rate is ranked better than
51.64% of 701 companies
in the Medical Devices & Instruments industry
Industry Median: 9.8 vs GMED: 10.80

Globus Medical's EPS (Diluted) for the three months ended in Dec. 2023 was $0.11. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.17.

Globus Medical's EPS (Basic) for the three months ended in Dec. 2023 was $0.11. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.18.


Globus Medical EPS without NRI Historical Data

The historical data trend for Globus Medical's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Globus Medical EPS without NRI Chart

Globus Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.68 1.05 1.63 1.92 1.42

Globus Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.49 0.60 0.57 0.60

Competitive Comparison of Globus Medical's EPS without NRI

For the Medical Devices subindustry, Globus Medical's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Globus Medical's PE Ratio without NRI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Globus Medical's PE Ratio without NRI falls into.



Globus Medical EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Globus Medical  (NYSE:GMED) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Globus Medical EPS without NRI Related Terms

Thank you for viewing the detailed overview of Globus Medical's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Globus Medical (Globus Medical) Business Description

Traded in Other Exchanges
Address
2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.
Executives
Leslie V Norwalk director C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Dan Wolterman director 3721 VALLEY CENTRE DR, SUITE 500, SAN DIEGO CA 92130
John A Deford director C R BARD INC, 730 CENTRAL AVENUE, MURRAY HILL NJ 07974
Dan Lemaitre director 2 MUSICK, IRVINE CA 92618
Keith W Pfeil officer: SVP, Chief Financial Officer GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
Kelly Huller officer: SVP, General Counsel 2560 GENERAL ARMISTEAD AVENUE, AUDOBON PA 19403
David D Davidar director, officer: Vice President, Operations C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
James R Tobin director C/O CURIS INC, 4 MAGUIRE ROAD, LEXINGTON MA 02421
Daniel T Scavilla officer: Senior VP and CFO C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
David M Demski director, officer: President and COO C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
Robert Andrew Douglas director 21 ATTUNGA ROAD, NEWPORT, NEW SOUTH WALES C3 2106
Stephen T Zarrilli director FIBERLINK COMMUNICATIONS CORP., 794 PENLLYN PIKE, BLUE BELL PA 19422
Anthony L Williams officer: Senior VP of Bus. Devel. & GC C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
Steven Payne officer: Chief Accounting Officer C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403
David C Paul director, 10 percent owner, officer: Chief Executive Officer C/O GLOBUS MEDICAL, INC., 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA 19403